. 2011 Dec 23;23(2):363–370. doi: 10.1007/s10552-011-9885-6

Table 5.

Hazard ratio (HR) and 95% confidence intervals (95% CI) of dying from all causes, in cancer-specific quartile groups of 25-OHD

	Breast	Colon	Lung	Lymphoma
1. Quartile (<46 nmol/L)	1.00 reference 27/45*	1.00 reference 11/13*	1.00 reference 63/63*	1.00 reference 24/40*
2. Quartile (46–61 nmol/L)	0.55 (0.32, 0.95) 25/62*	0.48 (0.18, 1.29) 8/12*	0.40 (0.28, 0.59) 55/62*	0.59 (0.32, 1.11) 18/34*
3. Quartile (62–81 nmol/L)	0.41 (0.23, 0.74) 20/58*	0.61 (0.23, 1.59) 11/17*	0.34 (0.22, 0.52) 38/44*	0.46 (0.25, 0.86) 20/43*
4. Quartile (>81 nmol/L)	0.37 (0.21, 0.67) 26/86*	0.40 (0.10, 1.60) 6/10*	0.19 (0.12, 0.30) 34/41*	0.33 (0.16, 0.69) 13/28*
p for trend	p < 0.01	p = 0.23	p < 0.01	p < 0.01

Breast

Colon

Lung

Lymphoma

HR (95% CI)**

1. Quartile

(<46 nmol/L)

1.00 reference

27/45*

1.00 reference

11/13*

1.00 reference

63/63*

1.00 reference

24/40*

2. Quartile

(46–61 nmol/L)

0.55 (0.32, 0.95)

25/62*

0.48 (0.18, 1.29)

8/12*

0.40 (0.28, 0.59)

55/62*

0.59 (0.32, 1.11)

18/34*

3. Quartile

(62–81 nmol/L)

0.41 (0.23, 0.74)

20/58*

0.61 (0.23, 1.59)

11/17*

0.34 (0.22, 0.52)

38/44*

0.46 (0.25, 0.86)

20/43*

4. Quartile

(>81 nmol/L)

0.37 (0.21, 0.67)

26/86*

0.40 (0.10, 1.60)

6/10*

0.19 (0.12, 0.30)

34/41*

0.33 (0.16, 0.69)

13/28*

p for trend

p < 0.01

p = 0.23

p < 0.01

* Number of fatal cases/Number of patients

** Adjusted for sex, age at diagnosis and season of blood sampling